Pulse Biosciences, Inc.
PLSE
$17.74
$0.855.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -19.39M | -12.68M | -11.38M | -10.14M | -11.93M |
| Total Depreciation and Amortization | 287.00K | 294.00K | 298.00K | 299.00K | 304.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.80M | 2.98M | 2.05M | 1.76M | 3.36M |
| Change in Net Operating Assets | 3.16M | 380.00K | 638.00K | -1.70M | 1.49M |
| Cash from Operations | -9.14M | -9.02M | -8.40M | -9.78M | -6.78M |
| Capital Expenditure | -53.00K | -38.00K | -29.00K | -5.00K | -43.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -53.00K | -38.00K | -29.00K | -5.00K | -43.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 48.26M | 61.84M | 13.00K | 305.00K | 804.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -59.00K | 56.00K | -278.00K | -- | 0.00 |
| Cash from Financing | 48.20M | 61.90M | -265.00K | 305.00K | 804.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.01M | 52.84M | -8.69M | -9.48M | -6.02M |